Drugs MVST IB - part 1

Random Science Quiz

Can you name the drugs from MVST IB - part 1?

Quiz not verified by Sporcle

embed
 plays        
How to Play
DescriptionDrug nameUse
Nitrovasodilator - produces NO
alpha-1 antagonist most commonly used
Reversible anticholinesterase - ionic interaction
Indirectly acting sympathomimetic amine - converted to octopamine by DBH - found in various foodstuffs
Inhibits clotting by inhibiting synthesis of factors II, VII, IX, IX and regulatory proteins C, S, Z
PPAR-gamma agonist
Binds to synaptobrevin to prevent vesicle release from inhibitory interneuron synapses with motor neurons
Binds to neurexins, causing massive ACh release from nerve terminals
Partial agonist at alpha-adrenoceptors - 5-HT agonist
Local anaesthetic - uncharged
Beta-1 antagonist used in heart failure
ACE inhibitor - prodrug, must be metabolised in liver
Anion exchange resin - prevents reuptake of bile acids from intestine
Local anaesthetic - slow onset/offset - use dependence at low rates of stimulation - class IA antidysrhythmic
Muscarinic receptor antagonist - very long duration of action
Depolarising blocker selective for ganglion nicotinic receptor
Blocks uptake of choline into neurons
Indirectly-acting sympathomimetic amine - weak inhibitor of MAO
Beta-adrenoceptor agonist
Cardiac glycoside - inhibits Na/K-ATPase
Cholinergic agonist - not selective between nicotinic/muscarinic receptors
Combined alpha- and beta-adrenoceptor antagonist
Used experimentally to inhibit dopamine beta-hydroxylase - also inhibits aldehyde dehyddrogenase
Irreversible anticholinesterase - activated by replacement of sulphur atom with oxygen, deoxified by plasma carboxylesterases
Irreversible alpha-adrenoceptor antagonist - blocks Uptake 2 (and Uptake 1 at 10x higher concs)
Tricyclic antidepressant - blocks NET
Selective antagonist for M3 muscarinic receptor
Non-selective beta-adrenoceptor antagonist
Non-selective phosphodiesterase inhibitor
Class III antidysrhythmic - prolongs AP and refractory period
Carbonic anhydrase inhibitor
Selective beta-2 agonist (slight effect on beta-1)
Selective non-depolarising neuromuscular blocker at NMJ - ester, broken down by spontaneous hydrolysis and plasma esterases
Involved with providing new blood flow to ischaemic tissues
Blocks release of NA evoked by APs (repeated low doses/aftermath of large dose) - indirect sympathomimetic actions (large doses)
Nitrovasodilator - produces NO - metabolised in liver to active drug
Osmotic diuretic - filtered at glomerulus, not reabsorbed
Selective antagonist for M1 muscarinic receptors
Co-released with NA or ACh - acts on purinoceptors (P2 > P1)
Direct acting vasodilator - metabolised to NO or cyanide
Calcium channel blocker - phenylalkylamine - class IV antidysrhythmic
Inhibits DOPA decarboxylase in periphery
Glucocorticoid receptor antagonist
Non-selective, reversible MAO inhibitor
Competitive antagonist for ganglionic nicotinic receptor - inactive at NMJ
Intracellular tetravalent polyamine - helps produce inward rectification of K+ channels
Non-specific endothelin receptor antagonist
Mild partial beta-1 agonist
Regulates expression of multiple angiogenic genes
Selective non-depolarising neuromuscular blocking agent at NMJ - long action, not hydrolysed
Cholinergic agonist - +-isomer hydrolysed by AChE
NOS inhibitor - not very selective for different forms
DescriptionDrug nameUse
Beta-1 agonist - weak beta-2 agonist
Irreversible anticholinesterase - organophosphorus agent
Reverse inhibition of AChE by organophosphorus agents
Nicotinic receptor antagonist - relatively non-selective between NMJ and ganglion at clinical doses
Selective MAO-A inhibitor
Cyclic heptapeptide inhibitor of glycoprotein IIb/IIIa receptor
K channel opener - also hirsutism effects
Calcium channel antagonist - dihydropyridine - affects L-type but not T-type channels
Competitive antagonist for ganglionic nicotinic receptors - inactive at NMJ
Selective inhibitor of phosphodiesterase type V (selectively breaks down cGMP)
Blocks If current in SA node
Mineralocorticoid receptor antagonist - potassium-sparing diuretic
Thiazide diuretic - blocks Na/Cl transport in early distal tubule
K channel opener - also NO donor
Acts on imidazoline receptors
Inhibits liver triglyceride production and VLDL secretion - increases levels of tissue plasminogen activator
Mineralocorticoid receptor agonist
Phosphodiesterase III inhibitor - inodilator
Non-peptide inhibitor of glycoprotein IIb/IIIa receptor
Tyrosine kinase inhibitor
Irreversibly alkylates muscarinic receptor
Acts on imidazoline receptors
Angiotensin II partial agonist
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Use-dependent block of ganglionic transmission
Blocks transporter carrying ACh into storage vesicles
ADP-ribosylates alpha-s - inhibits GTPase activity - sustained activation of adenylyl cyclase
Local anaesthetic - weak base - use-dependence and voltage-dependence
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Class IC antidysrhythmic
Plasminogen + anisoylated streptokinase
Depolarising blocker selective for NMJ nicotinic receptor - very short duration of action, broken down by BuChe - deficiency in enzyme activity can lead to prolonged action
Blocks Na channels from exterior - no use-dependence
Non-selective agonist for muscarnic receptors
Very potent alpha-2 agonist
Converted to alpha-methylNA - released as false transmitter - more potent at alpha-2, less potent at alpha-1
Progestagen receptor antagonist
Selective inhibitor of NOS in neurons
Irreversible antagonist at nicotinic NMJ receptors (no effect on ganglionic receptors)
Non-selective agonist for muscarinic receptors
Calcium channel agonist - dihydropyridine
Glucocorticoid receptor agonist
Muscarinic receptor agonist
Inhibits platelet activation by inhibiting binding of ADP to its receptor on platelets
Double chain recombinant human tissue plasminogen activator
Orally-acting hypoglycaemic agent - sulphonylurea
Medium 'reversible' anticholinesterase - binds to esteratic site and carbamoylates ACh
Immunosuppressant drug with antiproliferative effects
Monoclonal antibody against glycoprotein IIb/IIIa receptor - prevents platelet aggregation - also binds to vitronectin receptor
ADP-ribosylates alpha-i - prevents activation of Gi in response to stimulation
Beta-1 antagonist used in heart failure
Loop diuretic - blocks Na/K/2Cl transport in thick ascending limb
DescriptionDrug nameUse
Inhibits intestinal absorption of cholesterol - circulates enterohepatically
K channel opener
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Selective alpha-2 agonist
Calcium channel blocker - benzothiazepine
Non-selective alpha-adrenoceptor antagonist
Potent, irreversible inhibitor of iNOS in activated macrophages
K channel opener
Calcium sensitiser - increases cardiac Ca2+ binding efficiency to troponin - inhibits phosphodiesterase III
Slightly selective alpha-2 agonist (also alpha-1 actions) - omitting dose can lead to rebound hypertension
Binds to SNAREs involved in membrane fusion, preventing ACh release
Naturally occurring anticoagulant produced by basophils/mast cells - exposes active site of antithrombin III
Arteriolar vasodilator - unknown mechanism
Estrogen receptor antagonist
Selective MAO-B inhibitor
NSAID used to prevent thrombosis
Alpha-2 antagonist (some effect on alpha-1)
Binds to plasminogen activator, increasing generation of plasmin
Blocks release of neurotransmitter via phospholipase A2 - localises to membrane by K channel binding moiety
Phosphodiesterase III inhibitor - inodilator
Binds very tightly to VMAT-2, preventing loading of catecholamines into vesicles
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Non-peptide angiotensin II antagonist - acts on AT1 receptors
Interferes with normal function of microtubule growth
Selective alpha-1 antagonist (slight effect on alpha-2)
Tricyclic antidepressant - blocks NET
Competitive inhibitor of tyrosine hydroxylase
Selective alpha-1 agonist (some action on beta-1)
Blocks transport of adenosine into cells - phosphodiesterase type V inhibitor
Local anaesthetic (ester, weak base) - broken down by BuChE
Non-selective phosphodiesterase inhibitor
Selective beta-1 antagonist (slight effect on beta-2)
Quaternary local anaesthetic analogue - only effective if perfused inside cells
Selective alpha-2 antagonist (slight effect on alpha-1)
Progestagen receptor agonist
Inodilator used to treat canine dilated cardiomyopathy - calcium sensitiser
Inhibits HMG-CoA reductase - also many pleiotropic effects
Nitrovasodilator - produces NO - taken sublingually
COMT inhibitor
Single chain recombinant human tissue plasminogen activator
Illegal drug - blocks NET
Orally-acting hypoglycaemic agent - sulphonylurea
Uncompetitive inhibitor of phosphatase acting on IP1 --> inositol
Selective beta-2 antagonist (slight effect on beta-1)
Experimental cardiac glycoside
Depolarising blocker at NMJ
A1 receptor antagonist - non-selective phosphodiesterase inhibitor
Causes development of new blood vessels
SSRI - blocks 5-HT transporter in Uptake 1
ACE inhibitor
Lowers VLDL (and LDL) by stimulating lipoprotein lipase - may activate PPARs
Estrogen receptor agonist

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras